Overcoming IGF1R-mediated resistance to oncolytic HSV1 and radiotherapy via triple combination therapy
Alexandra A. Miller(The University of Texas MD Anderson Cancer Center), Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Stephanie M Bean(The University of Texas Health Science Center at Houston), Jiyeon Kim, Matthew P. Mullarkey(The University of Texas Health Science Center at Houston), Tae Jin Lee(The University of Texas Health Science Center), Minxin Huang(The University of Texas Health Science Center), E Antonio Chiocca(Global Cancer Institute), Lily Nguyen(The University of Texas MD Anderson Cancer Center), Amanda S. Kouaho(The University of Texas Health Science Center at Houston), Sunil Krishnan(The University of Texas MD Anderson Cancer Center), Min-Hye Noh(The University of Texas Health Science Center at Houston), Joshua Davis(The University of Texas Health Science Center at Houston), Zhongming Zhao(Vanderbilt University), Grace Nguyen(The University of Texas Southwestern Medical Center), Jin Muk Kang(The University of Texas Health Science Center at Houston)
Cited by 0
Related Papers
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
|Cell Reports|2018|1.3k
Computational tools for copy number variation (CNV) detection using next-generation sequencing data: features and perspectives
|BMC Bioinformatics|2013|593
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers
|Cell Reports|2018|396
Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth
|Cancer Cell|2015|336
Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis
|Clinical Cancer Research|2016|332